InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,178.00
(
-0.45%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.93
(
-0.57%
)
Bitcoin
60,217.98
(
-2.26%
)
Post# of 252424
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: genisi post# 89630

Tuesday, 02/02/2010 2:24:13 PM

Tuesday, February 02, 2010 2:24:13 PM

Post# of 252424

It sure lifts question marks for the long-acting GLP-1 class on thyroid c-cell hyperplasia and pancreatitis and so indeed lowering the risk for Byetta LAR.

Still, I don't think Byetta LAR will be approved 1st round.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up